phenazopyridine has been researched along with Urinary Retention in 5 studies
Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have found that administration of phenazopyridine decreased short-term urinary retention following surgery but other more recent trials have shown mixed results." | 8.12 | The effect of preoperative phenazopyridine on short-term urinary retention following urogynecologic surgery. ( Brong, K; Edenfield, A; Kesty, K; McSwain, S; Swift, S; Woll, A, 2022) |
| "Previous studies have found that administration of phenazopyridine decreased short-term urinary retention following surgery but other more recent trials have shown mixed results." | 4.12 | The effect of preoperative phenazopyridine on short-term urinary retention following urogynecologic surgery. ( Brong, K; Edenfield, A; Kesty, K; McSwain, S; Swift, S; Woll, A, 2022) |
| "Three ureteral obstructions were identified intraoperatively and none in the postoperative period." | 2.82 | Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial. ( Alas, AN; Barber, M; Chadi, SA; Davila, GW; Espaillat-Rijo, L; Hurtado, EA; Siff, L; Vaish, S; Zimberg, S, 2016) |
| "We report a case of neurogenic bladder and chronic urinary retention associated with MDMA abuse." | 1.35 | Neurogenic bladder and chronic urinary retention associated with MDMA abuse. ( Barrueto, F; Beuerle, JR, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| McSwain, S | 1 |
| Woll, A | 1 |
| Edenfield, A | 1 |
| Kesty, K | 1 |
| Brong, K | 1 |
| Swift, S | 1 |
| Dubinskaya, A | 1 |
| Sierra, T | 1 |
| Taylor, DL | 1 |
| Leung, K | 1 |
| Hall, CD | 1 |
| Flynn, MK | 1 |
| Espaillat-Rijo, L | 1 |
| Siff, L | 1 |
| Alas, AN | 1 |
| Chadi, SA | 1 |
| Zimberg, S | 1 |
| Vaish, S | 1 |
| Davila, GW | 1 |
| Barber, M | 1 |
| Hurtado, EA | 1 |
| Beuerle, JR | 1 |
| Barrueto, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Phenazopyridine on Prolapse Surgery Voiding Trials[NCT03065075] | Phase 3 | 152 participants (Actual) | Interventional | 2017-02-01 | Completed | ||
| Perioperative Administration of Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery[NCT03524339] | Phase 2/Phase 3 | 132 participants (Actual) | Interventional | 2018-08-01 | Completed | ||
| Evaluation of Ureteral Jets on Cystoscopy: A Randomized Controlled Trial[NCT02476448] | 176 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy[NCT05190939] | 276 participants (Actual) | Interventional | 2018-07-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Rate of postoperative urinary retention after pelvic organ prolapse surgery as determined by those who failed a standardized void trial. A successful void trial is defined as a postvoid residual of less than half of the voided volume. (NCT03065075)
Timeframe: postoperative day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Phenazopyridine | 28 |
| No Phenazopyridine | 27 |
Rate of postoperative urinary retention after pelvic organ prolapse surgery as determined by those who failed a standardized void trial. A successful void trial is defined as a postvoid residual of less than half of the voided volume. (NCT03065075)
Timeframe: postoperative day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Phenazopyridine | 30 |
| No Phenazopyridine | 25 |
Total and subscale scores reported. Total score range 0-35, with 0 being less symptomatic and 35 being more symptomatic. Total score is sum of individual questions. Seven subgroups address incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining, nocturia. Each subgroup is scored 0-5 with 5 being most symptomatic. The last question is independent, rates quality of life from 0 (best) to 6 (worst) (NCT03524339)
Timeframe: Within 1 week of surgery
| Intervention | Points (Median) |
|---|---|
| Placebo | 6 |
| Tamsulosin | 7 |
Failed voiding trial upon removal of catheter (NCT03524339)
Timeframe: Within 72 hours of surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 16 |
| Tamsulosin | 5 |
Treated for urinary tract infection with antibiotics or urinalysis or urine culture suggests infection. (NCT03524339)
Timeframe: Within 6 weeks after surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 6 |
| Tamsulosin | 4 |
Urinary retention that required homegoing catheterization (NCT03524339)
Timeframe: within 6 weeks of surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 7 |
| Tamsulosin | 5 |
Medical records will be followed prospectively for 6 weeks to assess for incidence of urinary tract infections within different groups. (NCT02476448)
Timeframe: 6 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Normal Saline | 10 |
| Dextrose 10% | 13 |
| Phenazopyridine | 9 |
| Sodium Fluorescein | 10 |
2 trials available for phenazopyridine and Urinary Retention
| Article | Year |
|---|---|
The Effect of Phenazopyridine on Immediate Postoperative Voiding After Prolapse Surgery: A Randomized Controlled Trial.
Topics: Anesthetics; Female; Humans; Middle Aged; Pelvic Organ Prolapse; Phenazopyridine; Postoperative Care | 2021 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
3 other studies available for phenazopyridine and Urinary Retention
| Article | Year |
|---|---|
The effect of preoperative phenazopyridine on short-term urinary retention following urogynecologic surgery.
Topics: Clinical Trials as Topic; Cystoscopy; Female; Humans; Phenazopyridine; Postoperative Complications; | 2022 |
Commentary: The effect of preoperative phenazopyridine on short-term urinary retention following urogynecologic surgery.
Topics: Anesthetics, Local; Humans; Phenazopyridine; Preoperative Care; Urinary Retention | 2021 |
Neurogenic bladder and chronic urinary retention associated with MDMA abuse.
Topics: Adult; Amphetamine-Related Disorders; Anti-Infective Agents, Urinary; Bethanechol; Central Nervous S | 2008 |